AGP Picks
View all

Sci-Tech Seattle: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Seattle.

Press releases published on July 23, 2026

Zonar Releases 2026 Back-to-School Readiness Report, Finding Large Readiness Gaps
AndaSeat Positions Axis Monitor Arm for the Shift Between Ultrawide Workflows and Vertical Content Creation
AndaSeat Explains How Motion Control and Installation Flexibility Shaped Its New Monitor Arm Series
AndaSeat Launches Monitor Arm Series as AI-Assisted Work Expands the Need for Adaptable Screen Positioning
20/20 BioLabs Announces Standstill Agreement with Streeterville Capital Regarding Series E Convertible Preferred Stock
Other World Computing (OWC) Announces OWC Express 4M2 Ultra – Fastest Compact Ready-To-Run Thunderbolt 5 NVMe RAID Solution, in 4TB, 8TB, 16TB, and 32TB Capacities
Wave Life Sciences Second Quarter 2026 Financial Results Scheduled for July 30, 2026
Lantheus to Host Second Quarter 2026 Earnings Conference Call and Webcast on August 6, 2026, at 8:00 a.m. Eastern Time
Intelligent Bio Solutions Achieves Key Milestone Ahead of Planned FDA 510(k) Submission, Advancing Toward Planned U.S. Market Entry
NewGen’s Strategic Pre-A Investment in K25.ai Doubles in Value as K25.ai’s Valuation Reaches US$200 Million
TruGolf Links Celebrates Grand Opening at Plaza at Cherry Hill
SodaSlim Releases Updated 2026 Highlights Soda Slim Capsules Ingredient Transparency, Formulation Details, Package Information, and Safety Considerations
Ardelyx to Report Second Quarter 2026 Financial Results on August 6, 2026
Collegium to Report Second Quarter 2026 Financial Results on August 6, 2026
Incannex Commences Participant Screening in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep Apnea
HiBob launches AI Skills Framework and a new AI Skills Assessment Guide to help organizations build workforce readiness for the AI Era
HCW Biologics Reaches Milestones for Its Proprietary Tetravalent Second-Generation T-Cell Engager Program On Track To Initiate Clinical Trials in First Half 2027
Atsena Therapeutics Receives Orphan Designation from the European Medicines Agency (EMA) for ATSN-101 and ATSN-201
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026
Inhibikase Therapeutics Announces FDA Orphan Drug Designation Granted to IKT-001 for the Treatment of PAH

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Sci-Tech Seattle

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.